C-READY (Cognitive-Remediation of Executive and Adaptive Deficits in Youth) for Self Efficacy

Phase-Based Progress Estimates
1
Effectiveness
2
Safety
University of Alabama at Birmingham, Birmingham, AL
Self Efficacy+6 More
CREADY (Cognitive-Remediation of Executive and Adaptive Deficits in Youth) - Behavioral
Eligibility
< 65
All Sexes
What conditions do you have?
Select

Study Summary

Randomized Controlled Trial (RTC) testing the efficacy of a telehealth adaptation of the Cognitive-Remediation of Executive and Adaptive Deficits in Youth (C-READY) intervention to prepare adolescents with sickle cell disease for transition of care.

Eligible Conditions

  • Skills, Coping
  • Sickle Cell Disease (SCD)
  • Self Efficacy
  • Health-Related Behavior
  • Cognitive Impairment (CI)
  • Adolescent Behaviors

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: 4-months post-intervention

4-months post-intervention
Cognitive Assessment
Transition Readiness
4-weeks
Neuroimaging

Trial Safety

Safety Progress

2 of 3
This is further along than 68% of similar trials

Trial Design

1 Treatment Group

C-READY (Cognitive-Remediation of Executive and Adaptive Deficits in Youth)
1 of 1
Experimental Treatment

120 Total Participants · 1 Treatment Group

Primary Treatment: C-READY (Cognitive-Remediation of Executive and Adaptive Deficits in Youth) · No Placebo Group · Phase 2

C-READY (Cognitive-Remediation of Executive and Adaptive Deficits in Youth)
Behavioral
Experimental Group · 1 Intervention: CREADY (Cognitive-Remediation of Executive and Adaptive Deficits in Youth) · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 4-months post-intervention

Trial Background

Prof. Donna Murdaugh, Assistant Professor
Principal Investigator
University of Alabama at Birmingham
Closest Location: University of Alabama at Birmingham · Birmingham, AL
Photo of university of alabama at birmingham  1Photo of university of alabama at birmingham  2Photo of university of alabama at birmingham  3
1991First Recorded Clinical Trial
1 TrialsResearching Self Efficacy
1066 CompletedClinical Trials

Eligibility Criteria

Age < 65 · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.